161 related articles for article (PubMed ID: 29475023)
1. The multifaceted roles of perlecan in fibrosis.
Lord MS; Tang F; Rnjak-Kovacina J; Smith JGW; Melrose J; Whitelock JM
Matrix Biol; 2018 Aug; 68-69():150-166. PubMed ID: 29475023
[TBL] [Abstract][Full Text] [Related]
2. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
Farach-Carson MC; Warren CR; Harrington DA; Carson DD
Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
[TBL] [Abstract][Full Text] [Related]
3. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
[TBL] [Abstract][Full Text] [Related]
4. Perlecan, the "jack of all trades" proteoglycan of cartilaginous weight-bearing connective tissues.
Melrose J; Hayes AJ; Whitelock JM; Little CB
Bioessays; 2008 May; 30(5):457-69. PubMed ID: 18404701
[TBL] [Abstract][Full Text] [Related]
5. Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains.
Kennett EC; Rees MD; Malle E; Hammer A; Whitelock JM; Davies MJ
Free Radic Biol Med; 2010 Jul; 49(2):282-93. PubMed ID: 20416372
[TBL] [Abstract][Full Text] [Related]
6. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
Shu CC; Smith SM; Little CB; Melrose J
Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
[TBL] [Abstract][Full Text] [Related]
7. Altered stress induced by partial transection of the infraspinatus tendon leads to perlecan (HSPG2) accumulation in an ovine model of tendinopathy.
Melrose J; Smith MM; Smith SM; Ravi V; Young AA; Dart AJ; Sonnabend DH; Little CB
Tissue Cell; 2013 Feb; 45(1):77-82. PubMed ID: 23245384
[TBL] [Abstract][Full Text] [Related]
8. Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes.
Johnson BB; Cosson MV; Tsansizi LI; Holmes TL; Gilmore T; Hampton K; Song OR; Vo NTN; Nasir A; Chabronova A; Denning C; Peffers MJ; Merry CLR; Whitelock J; Troeberg L; Rushworth SA; Bernardo AS; Smith JGW
Cell Rep; 2024 Jan; 43(1):113668. PubMed ID: 38198277
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrices of the avian ovarian follicle. Molecular characterization of chicken perlecan.
Hummel S; Osanger A; Bajari TM; Balasubramani M; Halfter W; Nimpf J; Schneider WJ
J Biol Chem; 2004 May; 279(22):23486-94. PubMed ID: 15016830
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.
Rees MD; Whitelock JM; Malle E; Chuang CY; Iozzo RV; Nilasaroya A; Davies MJ
Matrix Biol; 2010 Jan; 29(1):63-73. PubMed ID: 19788922
[TBL] [Abstract][Full Text] [Related]
11. Perlecan--a multifunctional extracellular proteoglycan scaffold.
Farach-Carson MC; Carson DD
Glycobiology; 2007 Sep; 17(9):897-905. PubMed ID: 17442708
[TBL] [Abstract][Full Text] [Related]
12. Perlecan: a major IL-2-binding proteoglycan in murine spleen.
Miller JD; Stevens ET; Smith DR; Wight TN; Wrenshall LE
Immunol Cell Biol; 2008 Feb; 86(2):192-9. PubMed ID: 18040286
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan.
Rnjak-Kovacina J; Tang F; Lin X; Whitelock JM; Lord MS
Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28846206
[TBL] [Abstract][Full Text] [Related]
14. Perlecan in Pericellular Mechanosensory Cell-Matrix Communication, Extracellular Matrix Stabilisation and Mechanoregulation of Load-Bearing Connective Tissues.
Guilak F; Hayes AJ; Melrose J
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800241
[TBL] [Abstract][Full Text] [Related]
15. The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor.
Bengtsson E; Mörgelin M; Sasaki T; Timpl R; Heinegård D; Aspberg A
J Biol Chem; 2002 Apr; 277(17):15061-8. PubMed ID: 11847210
[TBL] [Abstract][Full Text] [Related]
16. Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.
Grindel BJ; Martinez JR; Tellman TV; Harrington DA; Zafar H; Nakhleh L; Chung LW; Farach-Carson MC
Sci Rep; 2018 May; 8(1):7262. PubMed ID: 29740048
[TBL] [Abstract][Full Text] [Related]
17. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate.
Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U
J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923
[TBL] [Abstract][Full Text] [Related]
18. Impact of the heparan sulfate proteoglycan perlecan on human disease and health.
Arikawa-Hirasawa E
Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1117-C1122. PubMed ID: 35417267
[TBL] [Abstract][Full Text] [Related]
19. Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment.
Cruz LA; Tellman TV; Farach-Carson MC
Adv Exp Med Biol; 2020; 1245():133-146. PubMed ID: 32266656
[TBL] [Abstract][Full Text] [Related]
20. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
